TY - JOUR
T1 - Pulmonary tumor thrombotic microangiopathy FDG-PET/CT findings
AU - Tashima, Yoshiko
AU - Abe, Koichiro
AU - Matsuo, Yoshio
AU - Baba, Shingo
AU - Kaneko, Koichiro
AU - Isoda, Takuro
AU - Yabuuchi, Hidetake
AU - Sasaki, Masayuki
AU - Honda, Hiroshi
PY - 2009/3
Y1 - 2009/3
N2 - Pulmonary tumor thrombotic microangiopathy (PTTM) is his- topathologically characterized by proliferation of intimal myofibroblasts in the small pulmonary arterioles, induced by tumor microemboli. Patients develop rapidly progressive and severe cardiopulmonary failure, and the clinical course of this disease is fatal. Conventional radiologic findings are often minimal or nonspecific, making diagnosis difficult before death. We report 2-(F-18)-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) images of PTTM, which illustrate the characteristic findings of this clinical entity. FDG-PET can be helpful for the diagnosis of PTTM.
AB - Pulmonary tumor thrombotic microangiopathy (PTTM) is his- topathologically characterized by proliferation of intimal myofibroblasts in the small pulmonary arterioles, induced by tumor microemboli. Patients develop rapidly progressive and severe cardiopulmonary failure, and the clinical course of this disease is fatal. Conventional radiologic findings are often minimal or nonspecific, making diagnosis difficult before death. We report 2-(F-18)-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) images of PTTM, which illustrate the characteristic findings of this clinical entity. FDG-PET can be helpful for the diagnosis of PTTM.
UR - http://www.scopus.com/inward/record.url?scp=66849121648&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=66849121648&partnerID=8YFLogxK
U2 - 10.1097/RLU.0b013e3181966f5c
DO - 10.1097/RLU.0b013e3181966f5c
M3 - Article
C2 - 19352285
AN - SCOPUS:66849121648
SN - 0363-9762
VL - 34
SP - 175
EP - 177
JO - Clinical nuclear medicine
JF - Clinical nuclear medicine
IS - 3
ER -